Premium
Drugmaker Gland Pharma Ltd, the first Indian company controlled by a Chinese firm to float an initial public offering, has raised Rs 1,943.86 crore ($262.68 million at current exchange rates) from anchor investors led by Singapore sovereign wealth fund GIC. Hyderabad-based Gland Pharma, which is majority-owned by China’s Shanghai Fosun Pharmaceutical ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
